Company
Qureight
Enterprise-grade imaging and precision endpoints for clinical trials
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Headquarters
- Cambridge, United Kingdom
- Employees
- 60 peopleSource (opens in a new tab)
- Customers
- biopharma
- Legal name
- Qureight Ltd
- qureight.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 22 September 2026
About
Qureight is a tech-first, AI-powered imaging CRO. We deliver our suite of products through a proprietary data and imaging curation platform. This enables the analysis of clinical imaging and other healthcare data from patients with lung and heart disease, helping our customers bring treatments to market, faster.
Funding snapshot
- Total raised
- $20MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $20M2026-07-29
Funding rounds
- Series B
- $20M2026-07-29, Company stated
Products
- Web
- AI-powered endpoints and analytics
- Web
- Data science products
- Web
- Global imaging CRO services
Loading relationship preview